Literature DB >> 23838379

Breathlessness--current and emerging mechanisms, measurement and management: a discussion from an European Association of Palliative Care workshop.

David C Currow1, Irene J Higginson, Miriam J Johnson.   

Abstract

BACKGROUND: A pre-conference workshop at the 2012 European Association of Palliative Care meeting discussed the current scientific and clinical aspects of breathlessness. AIM: To describe a current overview of clinically relevant science in breathlessness.
DESIGN: A collation of workshop presentations and discussions. DATA SOURCES: Narrative review.
RESULTS: The mismatch between the drive to breathe and the ability to breathe underlies the major theories of breathlessness unifying central processing of peripheral inputs including more recent recognition of the importance of peripheral muscles in mediating efferent inputs, supporting reduction of breathlessness with muscle conditioning. Key questions are whether there is a 'final common pathway' for breathlessness? Are the central nervous system targets for reducing breathlessness identical irrespective of underlying aetiology? Central nervous system functional imaging confirms an ability to differentiate severity (intensity) from affective components (unpleasantness). Breathlessness generates suffering across the community for patients and their caregivers often for long periods. The exertional nature of breathlessness means that reduction rather than elimination of the symptom is the therapeutic goal. No single intervention is likely to relieve chronic refractory breathlessness, but interventions made up of several components may provide incremental relief. Having optimally treated any underlying reversible components, the resultant chronic refractory breathlessness can be treated with pharmacological, psychological and physical therapies to reduce the sensation and its impacts.
CONCLUSION: Ensuring optimal delivery of interventions for breathlessness, whose design is underpinned by improving the understanding in the aetiology and maintenance of breathlessness, is the subject of ongoing controlled clinical trials.

Entities:  

Keywords:  Dyspnoea; central modulation; clinical management; measurement; mechanism; peripheral modulation

Mesh:

Year:  2013        PMID: 23838379     DOI: 10.1177/0269216313493819

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  6 in total

1.  Fentanyl treatment for end-of-life dyspnoea relief in advanced cancer patients.

Authors:  Miguel Angel Benítez-Rosario; Inmaculada Rosa-González; Enrique González-Dávila; Emilio Sanz
Journal:  Support Care Cancer       Date:  2018-06-18       Impact factor: 3.603

2.  Is breathlessness what the professional says it is? Analysis of patient and professionals' assessments from a German nationwide register.

Authors:  Steffen T Simon; Nadine Altfelder; Bernd Alt-Epping; Claudia Bausewein; Vera Weingärtner; Raymond Voltz; Christoph Ostgathe; Lukas Radbruch; Gabriele Lindena; Friedemann Nauck
Journal:  Support Care Cancer       Date:  2014-02-19       Impact factor: 3.603

Review 3.  Episodic Breathlessness in Patients with Advanced Cancer: Characteristics and Management.

Authors:  Sebastiano Mercadante
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

4.  Contributions of a hand-held fan to self-management of chronic breathlessness.

Authors:  Tim Luckett; Jane Phillips; Miriam J Johnson; Morag Farquhar; Flavia Swan; Teresa Assen; Priyanka Bhattarai; Sara Booth
Journal:  Eur Respir J       Date:  2017-08-17       Impact factor: 16.671

5.  Hospital without dyspnea: rationale and design of a multidisciplinary intervention.

Authors:  Lourdes Vicent; Juan Manuel Nuñez Olarte; Luis Puente-Maestu; Esther Artajona; Francisco Fernández-Avilés; Manuel Martínez-Sellés
Journal:  J Geriatr Cardiol       Date:  2016-07       Impact factor: 3.327

Review 6.  Content and quality of websites supporting self-management of chronic breathlessness in advanced illness: a systematic review.

Authors:  Tim Luckett; Rebecca Disler; Annmarie Hosie; Miriam Johnson; Patricia Davidson; David Currow; Anthony Sumah; Jane Phillips
Journal:  NPJ Prim Care Respir Med       Date:  2016-05-26       Impact factor: 2.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.